CVS Health Corp. (CVS)
Stock analysis · NYSE · Healthcare · Medical - Healthcare Plans
CVS Health Corp. (CVS) is a publicly traded company in the Healthcare sector. Latest price: $90.88. Market cap $116.23B. Trailing PE 23.73. Dividend yield 2.93%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →1-Year Price
Earnings
Proprietary Signals
About CVS Health Corp.
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Valuation
| P/E (TTM) | 23.73× |
|---|---|
| P/S (TTM) | 0.28× |
| P/B | 1.45× |
| PEG | 3.71× |
| P/FCF (TTM) | 9.89× |
| EV / EBITDA | 13.51× |
| EV / Sales | 0.44× |
| Earnings Yield | 4.23% |
| Free Cash Flow Yield | 10.12% |
| Dividend Yield | 2.93% |
Fundamentals
| Enterprise Value | $181.21B |
|---|---|
| Revenue (TTM) | $415.09B |
| Net Income (TTM) | $4.92B |
| Free Cash Flow (TTM) | $14.37B |
| Net Debt | $64.98B |
| Working Capital | -$11.70B |
| Gross Margin | 14.15% |
| Operating Margin | 2.00% |
| Net Margin | 1.18% |
| Return on Equity | 6.43% |
| Return on Invested Capital | 4.09% |
Peers
Recent News
- Brokers Suggest Investing in CVS Health (CVS): Read This Before Placing a Bet
- CVS Health (CVS) Stock Declines While Market Improves: Some Information for Investors
- Did CVS Health Corporation Insiders Breach their Fiduciary Duties to Shareholders?
- CVS Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CVS Health Corporation - CVS
- Should You Buy CVS Health Stock While It's Under $100?
Related
Browse more tickers: sitemap